AAMI News March 2020, Volume 55, Issue 3
The use of VR videos for training healthcare professionals is a growing trend with peer-reviewed data to support its effectiveness.
AAMI and the Parenteral Drug Association have agreed to explore collaborations to further the missions of both organizations and enhance value to their members, stakeholders, and respective communities at large.
The Food and Drug Administration (FDA) has issued final guidance reclassifying—from Class III to Class II—medical image analyzers under product code MYN.
To help improve patient safety and patient care, AAMI will soon release a webinar focused on reducing alarm fatigue and publish a collection of reports on the management of clinical alarm safety for health technology professionals.
- News in Brief
- Using the Influencer Change Model for Alarm Management
- Minimizing Alarms with the Help of HTM Professionals
- Howard Community College Establishes BMET Apprenticeship Program
- AAMI Nominates Members for Board of Directors
- Advances in Deep Brain Stimulation Devices
- AAMI Exchange IoTXperience Demonstrates the Future of the Internet of Things
- Tech World: The Potential of Wearable Health Technology Devices
- The Big Picture: HTM Reaches Out to Local High School
- Asked & Answered: Device Disposal
- AAMI Foundation: Kilmer Scholarship & Grant Program Launched
- Career Center: Six Steps for Strategic Planning
- One on One with Maria Cvach
- AAMI All Star: Shanil (Shani) P. Haugen, PhD
- Members on the Move
- Standards Spotlight: AAMI Adopts Updated and Redesignated Series of Dialysis Standards
- AAMI Standards Monitor Digest
- Advertisers in this Issue